G.W. Duff

2.6k total citations · 1 hit paper
34 papers, 2.2k citations indexed

About

G.W. Duff is a scholar working on Immunology, Rheumatology and Oncology. According to data from OpenAlex, G.W. Duff has authored 34 papers receiving a total of 2.2k indexed citations (citations by other indexed papers that have themselves been cited), including 20 papers in Immunology, 10 papers in Rheumatology and 8 papers in Oncology. Recurrent topics in G.W. Duff's work include Rheumatoid Arthritis Research and Therapies (8 papers), Cytokine Signaling Pathways and Interactions (7 papers) and Immune Response and Inflammation (6 papers). G.W. Duff is often cited by papers focused on Rheumatoid Arthritis Research and Therapies (8 papers), Cytokine Signaling Pathways and Interactions (7 papers) and Immune Response and Inflammation (6 papers). G.W. Duff collaborates with scholars based in United Kingdom, United States and France. G.W. Duff's co-authors include Francesco S. di Giovine, AG Wilson, Alexandra I. F. Blakemore, N.C. Wood, Julian Symons, J.A. Symons, Peter R. Young, Anthony G. Wilson, E Oyarzún and Ying Wu and has published in prestigious journals such as Proceedings of the National Academy of Sciences, The Journal of Immunology and Gastroenterology.

In The Last Decade

G.W. Duff

33 papers receiving 2.1k citations

Hit Papers

Single base polymorphism in the human Tumour Necrosis Fac... 1992 2026 2003 2014 1992 250 500 750

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
G.W. Duff United Kingdom 20 1.1k 476 386 379 236 34 2.2k
P. J. Sinnott United Kingdom 18 1.3k 1.2× 680 1.4× 416 1.1× 358 0.9× 343 1.5× 27 2.8k
David Sankaran United Kingdom 7 1.1k 1.0× 494 1.0× 214 0.6× 225 0.6× 250 1.1× 10 2.1k
M Fotino United States 28 1.1k 1.0× 307 0.6× 356 0.9× 535 1.4× 148 0.6× 78 2.5k
Brian S. Andrews United States 20 1.6k 1.4× 279 0.6× 512 1.3× 849 2.2× 247 1.0× 44 2.9k
Nitza Lahat Israel 34 902 0.8× 540 1.1× 674 1.7× 283 0.7× 422 1.8× 126 3.3k
Ralph Giorno United States 24 924 0.8× 255 0.5× 374 1.0× 444 1.2× 148 0.6× 54 2.0k
Paul A. Gatenby Australia 28 1.6k 1.5× 266 0.6× 394 1.0× 715 1.9× 230 1.0× 99 3.4k
Chris Perrey United Kingdom 15 937 0.9× 572 1.2× 237 0.6× 162 0.4× 289 1.2× 18 2.0k
Olcay Yeğin Türkiye 21 921 0.8× 476 1.0× 311 0.8× 194 0.5× 88 0.4× 72 1.9k
J. Bart A. Crusius Netherlands 24 1.1k 1.0× 420 0.9× 435 1.1× 293 0.8× 159 0.7× 47 2.1k

Countries citing papers authored by G.W. Duff

Since Specialization
Citations

This map shows the geographic impact of G.W. Duff's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by G.W. Duff with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites G.W. Duff more than expected).

Fields of papers citing papers by G.W. Duff

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by G.W. Duff. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by G.W. Duff. The network helps show where G.W. Duff may publish in the future.

Co-authorship network of co-authors of G.W. Duff

This figure shows the co-authorship network connecting the top 25 collaborators of G.W. Duff. A scholar is included among the top collaborators of G.W. Duff based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with G.W. Duff. G.W. Duff is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Kondragunta, Venkateswarlu, et al.. (2010). 390 PROGRESSION OR INITIATION OF RADIOGRAPHIC KNEE OSTEOARTHRITIS AND THE INTERLEUKIN-1 RECEPTOR ANTAGONIST GENE: THE JOHNSTON COUNTY OSTEOARTHRITIS PROJECT. Osteoarthritis and Cartilage. 18. S171–S172. 1 indexed citations
2.
Mee, John, Michael J. Cork, Francesco S. di Giovine, G.W. Duff, & Richard Groves. (2006). Interleukin-1: A key inflammatory mediator in psoriasis?. Cytokine. 33(2). 72–78. 72 indexed citations
3.
Symons, Julian, et al.. (2005). Human interleukin-1α gene expression is regulated by Sp1 and a transcriptional repressor. Cytokine. 30(4). 141–153. 20 indexed citations
4.
Millard, Thomas P., E. Kondeatis, Angela Cox, et al.. (2001). A candidate gene analysis of three related photosensitivity disorders: cutaneous lupus erythematosus, polymorphic light eruption and actinic prurigo. British Journal of Dermatology. 145(2). 229–236. 40 indexed citations
5.
Cork, Michael J., Nicola J. Camp, John Mee, et al.. (1999). Genetic association between MHC S gene and susceptibility to psoriasis. Journal of Investigative Dermatology. 112(4). 591–591. 1 indexed citations
6.
Jones, Simon, Jennifer Mansfield, Francesco S. di Giovine, et al.. (1998). Further evidence of an association between the allele 2 of the interleukin-1 receptor antagonist (IL-1RA) gene (IL-1RN) polymorphism and ulcerative colitis (UC). Gastroenterology. 114. A948–A948. 1 indexed citations
7.
Cork, Michael J., AG Wilson, Alison M. Crane, et al.. (1996). Promoter region polymorphism in the human TNF‐α gene is not associated with lichen sclerosus. Experimental Dermatology. 5(4). 227–229. 3 indexed citations
8.
Cork, Michael J., et al.. (1996). Novel interleukin-1 receptor antagonist exon polymorphisms and their use in allele-specific mRNA assessment. Human Genetics. 97(6). 723–726. 12 indexed citations
9.
Symons, J.A., Peter R. Young, & G.W. Duff. (1995). Soluble type II interleukin 1 (IL-1) receptor binds and blocks processing of IL-1 beta precursor and loses affinity for IL-1 receptor antagonist.. Proceedings of the National Academy of Sciences. 92(5). 1714–1718. 176 indexed citations
10.
Stryckmans, Pierre, et al.. (1993). Efficacy and safety of cytokines for human therapy. Cytokine. 5(3). 180–184.
11.
Wilson, AG, Francesco S. di Giovine, Alexandra I. F. Blakemore, & G.W. Duff. (1992). Single base polymorphism in the human Tumour Necrosis Factor alpha (TNFα) gene detectable by Ncol restriction of PCR product. Human Molecular Genetics. 1(5). 353–353. 799 indexed citations breakdown →
12.
Wood, N.C., et al.. (1991). PLASMA LEVELS OF INTERLEUKIN-1-ALPHA IN RHEUMATOID ARTHRITIS. Lara D. Veeken. 30(4). 295–297. 22 indexed citations
13.
Symons, J.A., et al.. (1990). Identification of an interleukin‐1 beta binding protein in human plasma. FEBS Letters. 260(2). 213–216. 34 indexed citations
14.
Giovine, Francesco S. di, Stephen Poole, R D Situnayake, Meenu Wadhwa, & G.W. Duff. (1990). Absence of correlations between indices of systemic inflammation and synovial fluid interleukin 1 (alpha and beta) in rheumatic diseases. Rheumatology International. 9(6). 259–264. 22 indexed citations
15.
Symons, J.A. & G.W. Duff. (1990). A soluble form of the interleukin‐1 receptor produced by a human B cell line. FEBS Letters. 272(1-2). 133–136. 44 indexed citations
16.
Duff, G.W.. (1989). Interleukin 1 in rheumatoid arthritis. Biomedicine & Pharmacotherapy. 43(5). 389–390. 3 indexed citations
17.
Romero, Roberto, et al.. (1989). Human decidua: a source of interleukin-1.. PubMed. 73(1). 31–4. 186 indexed citations
18.
Symons, Julian, N.C. Wood, Francesco S. di Giovine, & G.W. Duff. (1988). Soluble IL-2 receptor in rheumatoid arthritis. Correlation with disease activity, IL-1 and IL-2 inhibition.. The Journal of Immunology. 141(8). 2612–2618. 234 indexed citations
19.
Ramsay, Colin A., Piers Forster, G. Nuki, & G.W. Duff. (1986). Inhibition of il1 driven t cell mitogenesis by synovial exudate fluids from patients with ra and oa. Lara D. Veeken. 1 indexed citations
20.
Cranston, W. I., et al.. (1973). The Bioassay of Human Endogenous Pyrogen. Clinical Science. 45(4). 449–458. 8 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026